Figure 2From: Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter studyPercent change from baseline in lipid levels after 6 weeks of treatment (Full Analysis Set population).Back to article page